The Japan Diabetes Society

JapaneseEnglish
SitemapSitemap

Vol.11 - No.3 (July 2020)

Vol.11 - No.3 (July 2020)

GUIDELINE

  Japanese Clinical Practice Guideline for Diabetes 2019
E. Araki, A. Goto, T. Kondo, M. Noda, H. Noto, H. Origasa, H. Osawa, A. Taguchi, Y. Tanizawa, K. Tobe, N. Yoshioka 165-223

CONSENSUS REPORT

  Medical nutrition therapy and dietary counseling for patients with diabetes -energy, carbohydrates, protein intake and dietary counseling
T. Yamauchi, H. Kamiya, K. Utsunomiya, H. Watada, D. Kawanami, J. Sato, M. Kitada, D. Koya, N. Harada, K. Shide, E. Joo, R. Suzuki, R. Bouchi, Y. Ohta, T. Kondo 224-239

COMMENTARY

  Ethics and practical mitigations for ongoing clinical trials during the COVID-19 pandemic
S. Suzuki, Y. Ito, S. Kasama, T. Murata, M. Matsuhisa, M. Kasahara 240-241

INTRODUCTION TO MINI-REVIEWS

  Current understanding of the effect of sodium-glucose co-transporter-2 inhibitors in Asian patients with diabetes mellitus
H. Watada 242-244

MINI-REVIEWS

  Significance of SGLT2 inhibitors: lessons from renal clinical outcomes in patients with type 2 diabetes and basic researches
M. Kitada, T. Hirai, D. Koya 245-251
  Promising roles of sodium-glucose cotransporter 2 inhibitors in heart failure prevention and treatment
A. Tanaka, K. Node 252-260

ORIGINAL ARTICLES

  Work-related, personal, and diabetes-related factors relevant to dropout from outpatient diabetes treatment visits among Japanese male employees with diabetes
N. Sonoda, S. Watanabe, Y. Ohno, K. Godai, C. Hatamochi, Y. Sugimoto, S. Okawa, M. Shikama, A. Morimoto 261-268
  Pathophysiology of gestational diabetes mellitus in lean Japanese pregnant women in relation to insulin secretion or insulin resistance
S. Inoue, Y. Kozuma, M. Miyahara, T. Yoshizato, Y. Tajiri, D. Hori, K. Ushijima 269-273
  Efficacy and safety of a combination of an insulin secretagogue and a dipeptidyl peptidase-4 inhibitor in Japanese patients with type 2 diabetes mellitus; the repaglinide glucose oscillation study in Fukuoka (REGO-F)
Y. Terawaki, C. Iwaya, T. Nomiyama, D. Shimono, T. Horikawa, Y. Fujimura-Tanaka, T. Shigeoka, N. Hamanoue, R. Motonaga, M. Tanabe, T. Yanase, D. Kawanami, Collaborators in the Repaglinide Glucose Oscillation Study in Fukuoka (REGO-F) trial 274-282
  Turkish version of the Michigan Neuropathy Screening Instrument in the assessment of diabetic peripheral neuropathy: a validity and reliability study
S. Kaymaz, H. Alkan, U. Karasu, V. Çobankara 283-292

SHORT COMMUNICATION

  Plasma lipopolysaccharide binding protein level statistically mediates between body mass index and chronic microinflammation in Japanese patients with type 1 diabetes
H. Watanabe, T. Katsura, M. Takahara, K. Miyashita, N. Katakami, T. Matsuoka, D. Kawamori, I. Shimomura 293-297

Update: July 29, 2020

SUB MENU